Wegovy Pill vs Shot: The Comparison Is 365 Protected Half-Hours Against 52 Injections

The short answer

They are the same drug at the same blood level. Choose on your calendar, not on effectiveness.

Both are covered by one FDA label — the same document, same boxed warning, same contraindications.

Why the timing rule exists

One line, so you do not talk yourself out of it: absolute bioavailability is 89% injected and 1–2% swallowed. The empty stomach and the 30-minute wait are what protect that 1–2%. Shortening the window is not taking a slightly weaker dose that day — it is changing the thing the trials controlled for.

What each form asks of a real week

The tablet asks for a protected half-hour, 365 times a year. Before anyone else is fed. No coffee, no juice, no breakfast, no other pills — and it has to be first, before the house starts making demands.

The injection asks for about ninety seconds, 52 times a year. Food is irrelevant. Abdomen, thigh or upper arm, rotating each dose, and then you stop thinking about it until next week. (Where to inject a GLP-1 has the rotation rule, and the one site Zepbound treats differently.)

If your mornings are not reliably yours, that is the whole comparison. If what you need is a program that bends around a week like that, the best GLP-1 for busy schedules board is scored on pausing a month and canceling without a phone call.

The clash nobody flags

The label says wait 30 minutes before any other oral medication — and that collides with a drug a lot of women in this readership already take.

Levothyroxine also wants an empty stomach in the morning. So does iron. If you are on either, you now have two medications competing for the same fasted half-hour, and stacking them is not a decision to make by guessing. Raise it before you start, not after.

Neither is the gentle option

This is the assumption worth killing, because it is the usual reason people ask about the tablet.

The label evaluated the 25 mg tablet in 204 adults, 76% of them women, and its verdict on side effects is one sentence: the types and frequency of common adverse reactions were similar to those listed in Table 3 — the injection's own table. That table reports nausea at 44%, diarrhea 30%, vomiting 24%, constipation 24%.

In the tablet's own trial, gastrointestinal adverse events occurred in 74.0% of the oral semaglutide group against 42.2% on placebo¹. Label rates for the two that most often reshape a week are in diarrhea on a GLP-1 and GLP-1 bloating and gas.

Swallowing it does not route the drug around your stomach. It routes it through it — the tablet is absorbed in the stomach.

What each one did in its trial

Do not subtract one from the other. Different trials, different sizes, different years, different placebo arms. No trial has ever randomized anyone between the two forms — the label's own position is that the 25 mg tablet reaches a blood level comparable to the 2.4 mg injection.

Pick the tablet if

• Needles are a genuine barrier, not a preference you could talk yourself out of
• Your mornings are predictable and yours
• You take no other morning-fasted medication

Pick the injection if

• Your mornings belong to other people
• You already take levothyroxine, iron, or anything else needing an empty stomach
• You would rather think about this once a week than every day
• You travel and cannot guarantee a fasted routine

Two things to ask before switching

Your dose does not carry across. The tablet has its own escalation — 1.5 mg daily for 30 days, then stepping every 30 days to 25 mg. Do not assume your injection dose maps to a tablet strength.

And if a step is rough, the instruction for both forms is identical: consider delaying the escalation rather than pushing through it. Hold, drop, or push through is how to ask.